Methylprednisolone reduces the risk of ovarian hyperstimulation syndrome (OHSS)

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1365, 2002-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study

By Carizza Carlos Abdelmassih Vicente Abdelmassih Soraya Ravizzini Pedro Salgueiro Lister Salgueiro Paulo Tudech Jine Lin Tao Nagy Peter Abdelmassih Roger

Reproductive BioMedicine Online, Vol. 17, Iss. 6, 2008-12 ,pp. : 751-755

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Pharmacotherapy of ovarian hyperstimulation syndrome

By Genazzani Andrea Riccardo Monteleone Patrizia Papini Francesca Artini Paolo Giovanni

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2527-2534

Informa Healthcare

Access to resources Recommend Favorite

Genetics of ovarian hyperstimulation syndrome

By Rizk Botros

Reproductive BioMedicine Online, Vol. 19, Iss. 1, 2009-07 ,pp. : 14-27

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Blood group A: an overseen risk factor for early-onset ovarian hyperstimulation syndrome?

By Binder Helge Flegel Willy A Emran Jasmin Müller Andreas Cupisti Susanne Beckmann Matthias W Eckstein Reinhold Dittrich Ralf Ringwald Juergen

Reproductive BioMedicine Online, Vol. 17, Iss. 2, 2008-08 ,pp. : 185-189

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Ovarian hyperstimulation syndrome: strategies for prevention

By Chen Dehan Burmeister Lynn Goldschlag Dan Rosenwaks Zev

Reproductive BioMedicine Online, Vol. 7, Iss. 1, 2003-07 ,pp. : 43-49

Reproductive Healthcare Ltd

Access to resources Recommend Favorite